Pharmicell Co (XKRX:005690) Other Long Term Assets : ₩3,030 Mil (As of Mar. 2024)

View and export this data going back to 1988. Start your Free Trial

What is Pharmicell Co Other Long Term Assets?

Pharmicell Co's other long-term assets for the quarter that ended in Mar. 2024 was ₩3,030 Mil.

Pharmicell Co's quarterly other long-term assets declined from Sep. 2023 (₩7,304 Mil) to Dec. 2023 (₩3,036 Mil) but then stayed the same from Dec. 2023 (₩3,036 Mil) to Mar. 2024 (₩3,030 Mil).

Pharmicell Co's annual other long-term assets increased from Dec. 2021 (₩3,579 Mil) to Dec. 2022 (₩4,288 Mil) but then declined from Dec. 2022 (₩4,288 Mil) to Dec. 2023 (₩3,036 Mil).

Pharmicell Co Other Long Term Assets Historical Data

The historical data trend for Pharmicell Co's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmicell Co Other Long Term Assets Chart

Pharmicell Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

3,653.81

3,551.91

3,578.79

4,287.81

3,036.45

Pharmicell Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long Term Assets	Get a 7-Day Free Trial															7,323.79	7,317.42	7,304.37	3,036.45	3,030.31

Pharmicell Co Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Pharmicell Co (XKRX:005690) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmicell Co Ltd (XKRX:005690) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

12F Chungho B/D, 3-2 Nonhyun-dong Gangnam-gu, Seoul, KOR, 135-010

Website

http://www.pharmicell.com

Pharmicell Co Ltd is a biotechnology company, engages in the manufacturing of biopharmaceutical medicines in South Korea. Its biopharmaceutical business engages in the development and manufacture of stem cell therapeutic drugs and stem cell-based cosmetics and others. Its products under development include mesenchymal stem cell products, such as Cellgram_AMI, a heart disease drug; Cellgram_IS and Cellgram_SCI, which are brain/nerve disorder drugs; Cellgram_Lung, a pulmonary disease drug; Cellgram_LC, a liver disease drug; and Cellgram_ED and Cellgram_CLI for the treatment of graft-versus-host disease, kidney transplant, impotence, and critical lower limb ischemia.

Pharmicell Co (XKRX:005690) Headlines

No Headlines